Inspire Investing LLC Buys New Position in Alignment Healthcare, Inc. $ALHC

Inspire Investing LLC bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 64,713 shares of the company’s stock, valued at approximately $1,129,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ALHC. SBI Securities Co. Ltd. boosted its holdings in shares of Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares in the last quarter. KBC Group NV acquired a new stake in Alignment Healthcare in the second quarter worth approximately $44,000. Signaturefd LLC boosted its stake in Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after purchasing an additional 2,215 shares in the last quarter. Greenleaf Trust acquired a new position in shares of Alignment Healthcare during the 2nd quarter valued at $160,000. Finally, Ballentine Partners LLC increased its position in shares of Alignment Healthcare by 10.2% during the 2nd quarter. Ballentine Partners LLC now owns 12,862 shares of the company’s stock valued at $180,000 after purchasing an additional 1,188 shares during the period. 86.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. The Goldman Sachs Group restated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. UBS Group boosted their target price on shares of Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, October 31st. Finally, JPMorgan Chase & Co. raised their target price on shares of Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $20.35.

Insider Transactions at Alignment Healthcare

In other news, insider Hyong Kim sold 51,379 shares of the firm’s stock in a transaction on Thursday, October 9th. The stock was sold at an average price of $17.57, for a total value of $902,729.03. Following the completion of the sale, the insider owned 362,333 shares of the company’s stock, valued at $6,366,190.81. This trade represents a 12.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Christopher J. Joyce sold 19,706 shares of Alignment Healthcare stock in a transaction on Monday, December 8th. The shares were sold at an average price of $19.33, for a total value of $380,916.98. Following the transaction, the insider owned 323,886 shares in the company, valued at $6,260,716.38. This represents a 5.74% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 842,157 shares of company stock worth $15,187,475. 7.00% of the stock is currently owned by insiders.

Alignment Healthcare Trading Down 4.0%

Shares of ALHC opened at $18.76 on Friday. The business’s 50-day moving average price is $18.12 and its 200 day moving average price is $16.12. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market capitalization of $3.75 billion, a P/E ratio of -156.30 and a beta of 1.16. Alignment Healthcare, Inc. has a 1-year low of $10.54 and a 1-year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The business’s revenue for the quarter was up 43.5% on a year-over-year basis. During the same period last year, the company posted ($0.14) earnings per share. Analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.